This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2121561-39-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Hong Kong
Inquiry
2121561-39-3 / 2-[3-(4-oxo-3H-quinazolin-2-yl)phenoxy]-N-propan-2-ylacetamide
Standard CAS: 2121561-39-3
Multi CAS: No
Basic Information
copy
CAS
2121561-39-3 copy
Multi CAS
No copy
Molecular Formula
C19H19N3O3 copy
Molecular Weight
337.400000 copy
Exact Mass
337.142641 copy
SMILES
CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=O)N2 copy
InChI
InChI=1S/C19H19N3O3/c1-12(2)20-17(23)11-25-14-7-5-6-13(10-14)18-21-16-9-4-3-8-15(16)19(24)22-18/h3-10,12H,11H2,1-2H3,(H,20,23)(H,21,22,24) copy
InChIKey
GCQOPGCYUDSLFP-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
25 copy
Aromatic heavy atom count
16 copy
Fraction Csp3
0.21 copy
Rotatable bonds
5 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
96.57 copy
TPSA
84.08 copy
LogP / Solubility
WLOGP
2.49 copy
MLOGP
2.21 copy
XLogP3
2.5 copy
Consensus LogP
2.4 copy
Log S (ESOL)
-3.65 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.13 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.52 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.01 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2.5 copy